自身免疫性肝炎患者骨质疏松性骨折风险增加
基于韩国国民健康保险服务2007至2020年理赔数据,自身免疫性肝炎患者7062例与28122例对照按1:4匹配。中位随访5.4年,患者组发生712例骨质疏松性骨折,发生率为17.5/1000人年,多因素分析发生比率比1.24(95%CI 1.10-1.39,P<0.01)。肝硬化与长期使用糖皮质激素进一步增加骨折风险。
要点
- 自身免疫性肝炎患者骨质疏松性骨折风险较对照升高,发生比率比1.24(95%CI 1.10-1.39,P<0.01)。
- 女性、高龄、卒中史、肝硬化及使用糖皮质激素与骨折风险增加相关。
- 2年界标分析中,糖皮质激素暴露时间越长,骨折风险递增。
核心结论
- 自身免疫性肝炎患者较对照的骨质疏松性骨折风险增加。
- 肝硬化和长期使用糖皮质激素进一步对自身免疫性肝炎患者的骨质疏松性骨折产生不利影响。
研究设计与样本
- 使用韩国国民健康保险服务2007至2020年理赔数据。
- 自身免疫性肝炎患者7062例与对照28122例按年龄、性别和随访时长以1:4匹配。
- 骨质疏松性骨折包括椎体、髋部、桡骨远端和肱骨近端骨折。
- 比较两组骨质疏松性骨折的发生率与发生比率并评估相关因素。
主要发现
- 中位随访5.4年期间,自身免疫性肝炎患者发生712例骨质疏松性骨折,发生率为17.5/1000人年。
- 多因素分析中自身免疫性肝炎患者骨质疏松性骨折风险较匹配对照显著升高,发生比率比1.24(95%CI 1.10-1.39,P<0.01)。
- 女性、高龄、卒中史、肝硬化及使用糖皮质激素与骨质疏松性骨折风险增加相关。
- 2年界标分析中,糖皮质激素暴露时间越长与骨质疏松性骨折风险递增相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Few large-scale studies have been published regarding the association between autoimmune hepatitis (AIH) and risk of osteoporotic fracture. This study aimed to determine the risk of developing an osteoporotic fracture in patients with AIH. METHODS: We used claims data from the Korean National Health Insurance Service between 2007 and 2020. Patients with AIH (n = 7,062) were matched with controls (n = 28,122) based on age, sex, and duration of follow-up using a ratio of 1:4. Osteoporotic fractures included fractures of the vertebrae, hip, distal radius, and proximal humerus. The incidence rate (IR) and IR ratio of osteoporotic fracture were compared between the 2 groups, and their associated factors were evaluated. RESULTS: During a median follow-up period of 5.4 years, 712 osteoporotic fractures occurred in patients with AIH with an IR of 17.5 per 1,000 person-years. Patients with AIH had a significantly higher risk of osteoporotic fractures than matched controls, with an IR ratio of 1.24 (95% confidence intervals, 1.10-1.39, P < 0.01) in the multivariable analysis. Female sex, older age, history of stroke, presence of cirrhosis, and use of glucocorticoids were associated with an increased risk of osteoporotic fractures. In the 2-year landmark analysis, longer duration of glucocorticoid exposure was associated with an incremental increased risk of osteoporotic fracture. DISCUSSION: Patients with AIH had an increased risk of osteoporotic fracture compared with controls. The presence of cirrhosis and long-term use of glucocorticoids further adversely affected osteoporotic fracture in patients with AIH.
引用
- Lim J, Kim YJ, Kim S, et al. Increased Risk of Osteoporotic Fracture in Patients With Autoimmune Hepatitis. Am J Gastroenterol. 2023. PMID: 37307538. doi:10.14309/ajg.0000000000002354
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。